Clinical trials sponsored by Second Affiliated Hospital of Nanchang University
7
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 1 1Phase 2 3Phase 3 1Phase 4 1Not applicable 3
Conditions studied
Recruiting trials led by Second Affiliated Hospital of Nanchang University
- Clinical Risk Score Prediction for Risk of Dementia Among Late-life Population With Depression
- Comparative Study on the Safety and Efficacy of Using AccuSafe Transseptal Guidewire Versus Traditional Transseptal Needle for Transseptal Puncture in non-or Free- Guidance
- Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC
- SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC
- Superselective Adrenal Arterial Embolization for Refractory Hypertension: A Proof-of-Concept Study
- The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
- Vebreltinib Plus Furmonertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer and High PD-L1 Expression
Common questions
How many trials is Second Affiliated Hospital of Nanchang University recruiting for?
Second Affiliated Hospital of Nanchang University is the lead sponsor of 7 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.